Recent advances in targeting protein kinases and pseudokinases in cancer biology
Kinases still remain the most favorable members of the druggable genome, and there are an increasing number of kinase inhibitors approved by the FDA to treat a variety of cancers. Here, we summarize recent developments in targeting kinases and pseudokinases with some examples. Targeting the cell cyc...
| Autores principales: | , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022-07-01
|
| Colección: | Frontiers in Cell and Developmental Biology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fcell.2022.942500/full |